A Message From Professor Rudy Nuijts, Sunday May 31, 2020

A Message From Professor Rudy Nuijts, Sunday May 31, 2020
Rudy Nuijts
Rudy Nuijts
Published: Sunday, May 31, 2020
Dear Colleagues Across the world, we are dealing with an unprecedented crisis in an ever-changing environment which is fraught with uncertainty. After much careful evaluation, ESCRS has decided that, regrettably, it will not be possible to hold a live congress in Amsterdam in October. Instead, ESCRS will host a Virtual Meeting planned from Friday 2 October to Sunday 4 October. It needs no further clarification that many of us were looking forward to the event, vigorously hoping that we would have been able to rejoin in Amsterdam as one of the first international events that could open up. It would have been a great occasion to exchange our experiences, get feedback from other places in the world and also have a great time as we were used to in the “old normal”. However, I have no doubt that we will become accustomed to the new time frame and will find innovative pathways to exchange at what we do best: provide the highest level of science and education in our field. I look forward to your continued support in the coming months and encourage all of you to sign up for the virtual meeting. Further this week, in our COVID-19 newsletter we bring you news on the successes and limitations of telemedicine while Jordi Mones in Spain exhorts us that we must convince our patients that it is safe for them to return to our clinics for evaluation and treatment. Two weeks ago, our American colleagues successfully organised their annual conference from a virtual platform in a very short timeframe. I congratulate them on their success although as I am sure you agree I would much preferred to have met them personally in Boston. We report today from that meeting where Matthew McCarthy and Francis Mah discussed infectious disease control in our clinics. Creativity and innovation are being sparked everywhere in our efforts to function during the time of this pandemic. We see today our colleagues in Israel are working on a COVID breathalyser test which could tell instantly if a patient presenting at our clinic has COVID-19. This could be a real game changer because in our report from a Columbia University Survey of residents, ophthalmologists ranked surprisingly high in their vulnerability to the virus. Please visit www.escrs.org for further details of our virtual congress. Stay safe and well  
Rudy Nuijts Prof. dr Rudy MMA Nuijts ESCRS President
 
Tags: covid 19 rudy nuijts
Latest Articles
Towards a Unified IOL Classification

The new IOL functional classification needs a strong and unified effort from surgeons, societies, and industry.

Read more...

The 5 Ws of Post-Presbyopic IOL Enhancement

Fine-tuning refractive outcomes to meet patient expectations.

Read more...

AI Shows Promise for Meibography Grading

Study demonstrates accuracy in detecting abnormalities and subtle changes in meibomian glands.

Read more...

Are There Differences Between Male and Female Eyes?

TOGA Session panel underlined the need for more studies on gender differences.

Read more...

Simulating Laser Vision Correction Outcomes

Individualised planning models could reduce ectasia risk and improve outcomes.

Read more...

Mastering IOL Exchange

Tips and tricks for an uncomplicated replacement procedure.

Read more...

Need to Know: Aberrations, Aberrometry, and Aberropia

Understanding the nomenclature and techniques.

Read more...

When Is It Time to Remove a Phakic IOL?

Close monitoring of endothelial cell loss in phakic IOL patients and timely explantation may avoid surgical complications.

Read more...

Delivering Uncompromising Cataract Care

Expert panel considers tips and tricks for cataracts and compromised corneas.

Read more...

Organising for Success

Professional and personal goals drive practice ownership and operational choices.

Read more...